Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC, as well as intends to offer hi branded men's and women's fashion from suppliers through its www.cbds.com website. In addition, the company holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and cannabis industries. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
The current price of DOGP is $0.01 USD — it has increased by +1.72% in the past 24 hours. Watch Dogecoin Cash stock price performance more closely on the chart.
What is Dogecoin Cash stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dogecoin Cash stocks are traded under the ticker DOGP.
Is Dogecoin Cash stock price growing?▼
DOGP stock has fallen by -0.67% compared to the previous week, the month change is a +1.72% rise, over the last year Dogecoin Cash has showed a -20.27% decrease.
What is Dogecoin Cash market cap?▼
Today Dogecoin Cash has the market capitalization of 2.36M
What is Dogecoin Cash revenue for the last year?▼
Dogecoin Cash revenue for the last year amounts to 1.6M USD.
What is Dogecoin Cash net income for the last year?▼
DOGP net income for the last year is -3.46M USD.
How many employees does Dogecoin Cash have?▼
As of April 01, 2026, the company has 4 employees.
When did Dogecoin Cash complete a stock split?▼
The last stock split for Dogecoin Cash was on December 15, 2025 with a ratio of 2:1.